Michael K. James

1.4k total citations
33 papers, 1.0k citations indexed

About

Michael K. James is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Anesthesiology and Pain Medicine. According to data from OpenAlex, Michael K. James has authored 33 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 14 papers in Cellular and Molecular Neuroscience and 5 papers in Anesthesiology and Pain Medicine. Recurrent topics in Michael K. James's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael K. James is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (8 papers) and Neuroscience and Neuropharmacology Research (6 papers). Michael K. James collaborates with scholars based in United States, Netherlands and Türkiye. Michael K. James's co-authors include Luigi X. Cubeddu, William E. Hoffman, Francesca Cunningham, Mary K. Grizzle, H J Leighton, Stephen V. Frye, H. Neal Bramson, Frank W. Lee, David Hermann and Kenneth W. Batchelor and has published in prestigious journals such as Journal of Applied Physiology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Michael K. James

33 papers receiving 976 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael K. James United States	18	359	335	258	159	118	33	1.0k
R. Daniel Mellon United States	14	207 0.6×	247 0.7×	325 1.3×	136 0.9×	276 2.3×	16	1.2k
Melik Seyrek Türkiye	17	213 0.6×	210 0.6×	57 0.2×	96 0.6×	18 0.2×	43	990
Takashi Okura Japan	22	336 0.9×	296 0.9×	57 0.2×	58 0.4×	9 0.1×	64	1.3k
Steven N. Ebert United States	20	1.1k 2.9×	225 0.7×	92 0.4×	137 0.9×	16 0.1×	32	1.8k
Takao Aoyama Japan	16	139 0.4×	163 0.5×	108 0.4×	48 0.3×	31 0.3×	72	957
Babette Kögel Germany	19	302 0.8×	386 1.2×	361 1.4×	262 1.6×	13 0.1×	30	1.4k
H. Fuder Germany	21	749 2.1×	469 1.4×	37 0.1×	119 0.7×	6 0.1×	62	1.3k
C. Mclean Australia	19	228 0.6×	53 0.2×	254 1.0×	382 2.4×	20 0.2×	47	1.0k
Martha M. Abou‐Donia United States	17	215 0.6×	103 0.3×	456 1.8×	252 1.6×	75 0.6×	33	951
M. Fiege Germany	14	489 1.4×	189 0.6×	48 0.2×	105 0.7×	9 0.1×	43	922

Countries citing papers authored by Michael K. James

Since Specialization

Citations

This map shows the geographic impact of Michael K. James's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael K. James with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael K. James more than expected).

Fields of papers citing papers by Michael K. James

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael K. James. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael K. James. The network helps show where Michael K. James may publish in the future.

Co-authorship network of co-authors of Michael K. James

This figure shows the co-authorship network connecting the top 25 collaborators of Michael K. James. A scholar is included among the top collaborators of Michael K. James based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael K. James. Michael K. James is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hildebrandt, Ian M., et al.. (2024). Demonstration of Inappropriate Validation Method for a Cracker Baking Process Using Predictive Modeling. Journal of Food Protection. 87(7). 100298–100298. 1 indexed citations

Hildebrandt, Ian M., et al.. (2021). Process Humidity Affects Salmonella Lethality at the Surface and Core of Impingement-Cooked Meat and Poultry Products. Journal of Food Protection. 84(9). 1512–1523. 1 indexed citations

James, Michael K., et al.. (2019). Survival and Thermal Resistance of Salmonella Enteritidis PT 30 on Almonds after Long-Term Storage. Journal of Food Protection. 82(2). 194–199. 26 indexed citations

James, Michael K., et al.. (2018). Inoculation Protocols Influence the Thermal Resistance of Salmonella Enteritidis PT 30 in Fabricated Almond, Wheat, and Date Products. Journal of Food Protection. 81(4). 606–613. 30 indexed citations

Jeong, Sanghyup, Bradley P. Marks, & Michael K. James. (2016). Comparing Thermal Process Validation Methods for Salmonella Inactivation on Almond Kernels. Journal of Food Protection. 80(1). 169–176. 13 indexed citations

Sherrill, Ronald G., Judd Berman, Dallas K. Croom, et al.. (2001). 1,4-Benzodiazepine Peripheral Cholecystokinin (CCK-A) Receptor Agonists. Bioorganic & Medicinal Chemistry Letters. 11(9). 1145–1148. 22 indexed citations

Hoke, John F., Francesca Cunningham, Michael K. James, Keith T. Muir, & William E. Hoffman. (1997). Comparative Pharmacokinetics and Pharmacodynamics of Remifentanil, Its Principle Metabolite (GR90291) and Alfentanil in Dogs. Journal of Pharmacology and Experimental Therapeutics. 281(1). 226–232. 85 indexed citations

Henke, Brad R., Christopher Aquino, Larry S. Birkemo, et al.. (1997). Optimization of 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines as Potent, Orally Active CCK-A Agonists. Journal of Medicinal Chemistry. 40(17). 2706–2725. 63 indexed citations

Bramson, H. Neal, David Hermann, Kenneth W. Batchelor, et al.. (1997). Unique Preclinical Characteristics of GG745, A Potent Dual Inhibitor of 5AR. Journal of Pharmacology and Experimental Therapeutics. 282(3). 1496–1502. 116 indexed citations

10.

James, Michael K., et al.. (1996). Section Reviews: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthnlis: Pharmacological approaches to correct the bioelectric deficits in cystic fibrosis. Expert Opinion on Investigational Drugs. 5(9). 1163–1171. 1 indexed citations

11.

Henke, Brad R., Timothy M. Willson, Elizabeth E. Sugg, et al.. (1996). 3-(1H-Indazol-3-ylmethyl)-1,5-benzodiazepines: CCK-A Agonists That Demonstrate Oral Activity as Satiety Agents. Journal of Medicinal Chemistry. 39(14). 2655–2658. 20 indexed citations

12.

Dezube, Milana, Elizabeth E. Sugg, Larry S. Birkemo, et al.. (1995). Modification of Receptor Selectivity and Functional Activity in Cholecystokinin Peptoid Ligands. Journal of Medicinal Chemistry. 38(17). 3384–3390. 16 indexed citations

13.

Lutz, Michael W., Paul H. Morgan, Michael K. James, et al.. (1994). A pharmacodynamic model to investigate the structure-activity profile of a series of novel opioid analgesics.. Journal of Pharmacology and Experimental Therapeutics. 271(2). 795–803. 3 indexed citations

14.

James, Michael K., et al.. (1992). Hemodynamic effects of GI 87084B, an ultra-short acting mu-opioid analgesic, in anesthetized dogs.. Journal of Pharmacology and Experimental Therapeutics. 263(1). 84–91. 48 indexed citations

15.

James, Michael K., et al.. (1991). Opioid receptor activity of GI 87084B, a novel ultra-short acting analgesic, in isolated tissues.. Journal of Pharmacology and Experimental Therapeutics. 259(2). 712–718. 95 indexed citations

16.

James, Michael K. & Luigi X. Cubeddu. (1987). Pharmacologic characterization and functional role of muscarinic autoreceptors in the rabbit striatum.. Journal of Pharmacology and Experimental Therapeutics. 240(1). 203–215. 65 indexed citations

17.

Garrett, Lillian, et al.. (1987). Ionic mechanism of dopaminergic and muscarinic auto- and heteroreceptor activation in superfused striatal slices: role of extracellular chloride.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 795–801. 6 indexed citations

18.

James, Michael K. & Luigi X. Cubeddu. (1984). Frequency-dependent muscarinic receptor modulation of acetylcholine and dopamine release from rabbit striatum.. Journal of Pharmacology and Experimental Therapeutics. 229(1). 98–104. 60 indexed citations

19.

Cubeddu, Luigi X., Irene Hoffmann, & Michael K. James. (1983). Frequency-dependent effects of neuronal uptake inhibitors on the autoreceptor-mediated modulation of dopamine and acetylcholine release from the rabbit striatum.. Journal of Pharmacology and Experimental Therapeutics. 226(1). 88–94. 45 indexed citations

20.

Cubeddu, Luigi X., Irene Hoffmann, Michael K. James, & Donna Niedzwiecki. (1983). Changes in the sensitivity to apomorphine of dopamine receptors modulating dopamine and acetylcholine release after chronic treatment with bromocriptine or haloperidol.. Journal of Pharmacology and Experimental Therapeutics. 226(3). 680–685. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact